MGX · Metagenomi Therapeutics, Inc.
Market Cap
$44.95M
Shares
37.78M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding MGX
13 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 741,407 | $882,274 | 0.00% | Long | 2026-06-30 | |
| Ultra-Small Company Fund | BRUSX | 327,100 | $389,249 | 0.39% | Long | 2026-06-30 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 315,460 | $375,397 | 0.00% | Long | 2026-06-30 | |
| Fidelity Extended Market Index Fund | FSMAX | 189,092 | $257,165 | 0.00% | Long | 2026-05-31 | |
| iShares Micro-Cap ETF | IWC | 95,479 | $113,620 | 0.01% | Long | 2026-06-30 | |
| Ultra-Small Company Market Fund | BRSIX | 62,200 | $74,018 | 0.05% | Long | 2026-06-30 | |
| Fidelity Total Market Index Fund | FSKAX | 47,211 | $64,207 | 0.00% | Long | 2026-05-31 | |
| Fidelity Series Total Market Index Fund | FCFMX | 36,088 | $49,080 | 0.00% | Long | 2026-05-31 | |
| Fidelity Nasdaq Composite Index Fund | FNCMX | 21,951 | $29,853 | 0.00% | Long | 2026-05-31 | |
| VANGUARD BALANCED INDEX FUND | — | 20,833 | $24,791 | 0.00% | Long | 2026-06-30 | |
| 1290 VT Micro Cap Portfolio | — | 6,882 | $8,190 | 0.00% | Long | 2026-06-30 | |
| Spectrum Fund | — | 5,496 | $6,540 | 0.00% | Long | 2026-06-30 | |
| Blackstone Alternative Multi-Strategy Fund | — | 2,600 | $3,094 | 0.00% | Long | 2026-06-30 |
Showing 1–13 of 13 positions
Key facts
CIK
1785279
CUSIP
59102M104
13F (30d)
40 filings
40 filers
Visit website
Investor relations